Skip to main content

US ClosedU.S. Closed

RCUS: Arcus Biosciences, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Arcus Biosciences, Inc. , a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States.

52W Range

88thpctl

Volume

0.87×avg

Market Cap

3.67BUSD

P/E Ratio

-7.4TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Arcus Biosciences, Inc.

RCUSNew York Stock Exchange·USD·Closed

Arcus Biosciences, Inc.

RCUSNew York Stock Exchange·USD·Closed

$29.21

−4.51%

$29.21

−$1.38 (4.51%)

52W Range

88thpctl

Volume

0.87×avg

Mkt Cap

3.67BUSD

P/E

-7.4TTM

Div Yield

–ann